000			01825 a2200493 4500
005			20250511193833.0
264		0	_c19920715
008			199207s 0 0 eng d
022			_a0272-0590
024	7		_a10.1016/0272-0590(92)90044-i _2doi
040			_aNLM _beng _cNLM
100	1		_aJones, M M
245	0	0	_aControl of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. _h[electronic resource]
260			_bFundamental and applied toxicology : official journal of the Society of Toxicology _cFeb 1992
300			_a181-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBiotin _xtherapeutic use
650	0	4	_aBlood Urea Nitrogen
650	0	4	_aCaptopril _xtherapeutic use
650	0	4	_aCefoxitin _xtherapeutic use
650	0	4	_aCephalexin _xtherapeutic use
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aCreatinine _xblood
650	0	4	_aDrug Interactions
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aKidney _xanatomy & histology
650	0	4	_aKidney Diseases _xchemically induced
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred DBA
650	0	4	_aOrgan Size _xdrug effects
650	0	4	_aPenicillin G _xtherapeutic use
650	0	4	_aRats
650	0	4	_aRats, Inbred Strains
650	0	4	_aSulfathiazoles _xtherapeutic use
650	0	4	_aSulfur _xtherapeutic use
650	0	4	_aThiamine _xtherapeutic use
700	1		_aBasinger, M A
700	1		_aHolscher, M A
773	0		_tFundamental and applied toxicology : official journal of the Society of Toxicology _gvol. 18 _gno. 2 _gp. 181-8
856	4	0	_uhttps://doi.org/10.1016/0272-0590(92)90044-i _zAvailable from publisher's website
999			_c1607700 _d1607700